Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:46 AM
NCT ID:
NCT00329160
Group ID:
EG000
Title:
Rosuvastatin
Description:
rosuvastatin 2.5 mg once daily; in those whose LDL-C remained \>80 mg/dl after 4 weeks of treatment, the dosage could be titrated up to a maximum of 20 mg/day, which is the highest approved regimen by the Ministry of Health, Labor and Welfare of Japan. Subjects attended follow-up visits every 4 weeks over 76 weeks after starting treatment with rosuvastatin.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
98
Serious Number At Risk:
213
Other Number Affected:
588
Other Number At Risk:
214
Study:
NCT00329160
Results Section:
NCT00329160
Adverse Events Module:
NCT00329160